Russian Federation registers second coronavirus vaccine, says third on the way

Clay Curtis
October 16, 2020

"As far as I know, we already have a third vaccine in development", he added, which is now being tested at the Chumakov research centre of the Russian Academy of Sciences.

China has been inoculating essential workers with COVID-19 vaccine candidates under an emergency use programme launched in July.

The second Russian vaccine to receive regulatory approval was developed by the Vector State Research Centre of Virology and Biotechnology.

YouTube's move comes a day after Facebook said it banned anti-vaccine ads globally. In this file photo taken on September 24, an employee of SinoVac works in a lab at a factory producing its SARS CoV-2 Vaccine for COVID-19 named CoronaVac in Beijing.

Sinovac has passed the review of a vaccine experts panel to conduct Phase 3 clinical trials and is expected to submit as early as this week its application with the Philippines' Food and Drug Administration, Eric Domingo, the agency's director general, said in a virtual briefing Thursday.

Coronavirus | European cases rocket, strong limits needed
At a virtual press conference on Thursday, WHO ( World Health Organization ) Regional Director for Europe Dr. Germany also registered 33 new deaths in the last 24 hours, the RKI added, bringing its total to 9,710.

Bio Farma, a state-owned firm in Indonesia which has reached a deal for at least 40 million doses from Sinovac, said this week the vaccine will cost around 200,000 rupiah (£10.48) per dose when it becomes available in the southeast Asian country.

YouTube is cracking down on misinformation regarding COVID-19 vaccines, announcing a ban on videos that include claims about coronavirus vaccinations that contradict information from health authorities.

"A COVID-19 vaccine may be imminent; therefore, we're ensuring we have the right policies in place to be able to remove misinformation related to a COVID-19 vaccine", a YouTube rep said in a statement.

Domingo told reporters a November trial start was "possible".

Eleven Chinese vaccines are now at the stage of clinical trials - with four in advanced Phase Three trials - nut none has been approved for mass market distribution.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER